# Safety Study Using GSK573719 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease

> **NCT00515502** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 24 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** GSK573719
- **DRUG:** Tiotropium

## Key facts

- **NCT ID:** NCT00515502
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06-21
- **Primary completion:** 2007-11-06
- **Final completion:** 2007-11-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00515502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00515502, "Safety Study Using GSK573719 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00515502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*